Endogenous endophthalmitis in a rheumatoid patient on tumor necrosis factor alpha blocker
The development of anti-tumor necrosis factor (TNF) therapies is a milestone in the therapy of rheumatic diseases.It is of concern whether all potential undesired Bile Acid complications of therapy have been evaluated within clinical trials which have led to treatment approval.Specialists prescribing TNF blockers should be aware of the unusual and